WHO-led COVID drug scheme doubles down on antibodies
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids.
All News Here
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids.
Japanese govt will fast-track a review of Gilead Sciences Inc’s antiviral drug remdesivir so that it can hopefully be approved…